773
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

19F Oximetry with semifluorinated alkanes

, , , , &
Pages 1861-1866 | Received 31 Jul 2015, Accepted 13 Oct 2015, Published online: 02 Dec 2015

References

  • Barker BR, Mason RP, Bansal N, Peshock RM. 1994. Oxygen tension mapping with F-19 echo-planar MR imaging of sequestered perfluorocarbon. J Magn Reson Imaging. 4:595–602.
  • Bellemann ME, Brückner J, Peschke P, Brix G, Mason RP. 2002. Quantification and visualization of oxygen partial pressure in vivo by 19F NMR imaging of perfluorocarbons. Biomed Tech (Berl). 47:451–454.
  • Dardzinski BJ, Sotak CH. 1994. Rapid tissue oxygen tension mapping using 19F inversion-recovery echo-planar imaging of perfluoro-15-crown-5-ether. Magn Reson Med. 32:88–97.
  • Domsch S, Mie MB, Wenz F, Schad LR. 2014. Non-invasive multiparametric qBOLD approach for robust mapping of the oxygen extraction fraction. Z Med Phys. 24:231–242.
  • Giraudeau C, Flament J, Marty B, Boumezbeur F, Meriaux S, Robic C, et al. 2010. A new paradigm for high-sensitivity 19F magnetic resonance imaging of perfluorooctylbromide. Magn Reson Med. 63:1119–1124.
  • Graves EE, Giaccia AJ. 2007. Imaging tumoral hypoxia: oxygen concentrations and beyond. Oncology (Williston Park). 21:368–376 (discussion 377–378, 384).
  • Horsman MR, Mortensen LS, Petersen JB, Busk M, Overgaard J. 2012. Imaging hypoxia to improve radiotherapy outcome. Nat Rev Clin Oncol. 9:674–687.
  • Kodibagkar VD, Wang X, Mason RP. 2008. Physical principles of quantitative nuclear magnetic resonance oximetry. Front Biosci. 13:1371–1384.
  • Le TD, Arlauskas RA, Weers JG. 1996. Characterization of the lipophilicity of fluorocarbon derivatives containing halogens or hydrocarbon blocks. J Fluor Chem. 78:155–163.
  • Liu S, Shah SJ, Wilmes LJ, Feiner J, Kodibagkar VD, Wendland MF, et al. 2011. Quantitative tissue oxygen measurement in multiple organs using 19F MRI in a rat model. Magn Reson Med. 66:1722–1730.
  • Mackiewicz J, Mühling B, Hiebl W, Meinert H, Maaijwee K, Kociok N, et al. 2007. In vivo retinal tolerance of various heavy silicone oils. Invest Ophthalmol Vis Sci. 48:1873.
  • Mason RP, Rodbumrung W, Antich PP. 1996. Hexafluorobenzene: a sensitive 19F NMR indicator of tumor oxygenation. NMR Biomed. 9:125–134.
  • Mason RP, Shukla H, Antich PP. 1993. In vivo oxygen tension and temperature: simultaneous determination using 19F NMR spectroscopy of perfluorocarbon. Magn Reson Med. 29:296–302.
  • Mason RP, Shukla H, Antich PP. 1992. Oxygent: a novel probe of tissue oxygen tension. Biomater Artif Cells Immobilization Biotechnol. 20:929–932.
  • Meinert H, Knoblich A. 1993. The use of semifluorinated alkanes in blood-substitutes. Biomater Artif Cells Immobilization Biotechnol. 21:583–595.
  • Meinert H, Roy T. 2000. Semifluorinated alkanes – a new class of compounds with outstanding properties for use in ophthalmology. Eur J Ophthalmol. 10:189–197.
  • Mignion L, Magat J, Schakman O, Marbaix E, Gallez B, Jordan BF. 2013. Hexafluorobenzene in comparison with perfluoro-15-crown-5-ether for repeated monitoring of oxygenation using 19F MRI in a mouse model. Magn Reson Med. 69:248–254.
  • Northoff H, Haidmann L, Hänsch G, Reuter P, Mader J, Meinert H, 1992. Biocompatibility of synthetic oxygen carriers and fluorosurfactants. Infusionstherapie. 19:115–120.
  • Padhani AR, Krohn KA, Lewis JS, Alber M. 2007. Imaging oxygenation of human tumours. Eur Radiol. 17:861–872.
  • Parhami P, Fung BM. 1983. Fluorine-19 relaxation study of perfluoro chemicals as oxygen carriers. J Phys Chem. 87:1928–1931.
  • Riess JG, Krafft MP. 1998. Fluorinated materials for in vivo oxygen transport (blood substitutes), diagnosis and drug delivery. Biomaterials. 19:1529–1539.
  • Shukla HP, Mason RP, Woessner DE, Antich PP. 1995. A comparison of three commercial perfluorocarbon emulsions as high-field 19F NMR probes of oxygen tension and temperature. J Magn Reson B. 106:131–141.
  • Sotak CH, Hees PS, Huang HN, Hung MH, Krespan CG, Raynolds S. 1993. A new perfluorocarbon for use in fluorine-19 magnetic resonance imaging and spectroscopy. Magn Reson Med. 29:188–195.
  • Tatum JL, Kelloff GJ, Gillies RJ, Arbeit JM, Brown JM, Chao KSC, et al. 2006. Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol. 82:699–757.
  • Thomas SR, Pratt RG, Millard RW, Samaratunga RC, Shiferaw Y, Clark LC, Hoffmann RE. 1994. Evaluation of the influence of the aqueous phase bioconstituent environment on the F-19 T1 of perfluorocarbon blood substitute emulsions. J Magn Reson Imaging. 4:631–635.
  • Tressaud A, Günter H. 2008. Fluorine and health molecular imaging, biomedical materials and pharmaceuticals. Amsterdam Boston: Elsevier Science, 2008, ISBN 9780080558110.
  • Tsagogiorgas C, Krebs J, Pukelsheim M, Beck G, Yard B, Theisinger B, Quintel M, Luecke T. 2010. Semifluorinated alkanes – a new class of excipients suitable for pulmonary drug delivery. Eur J Pharm Biopharm. 76:75–82.
  • Tsagogiorgas C, Theisinger S, Heesch E, Krebs J, Holm R, Beck G, Yard B. 2015. Evaluation of pharmacokinetic properties and anaesthetic effects of propofol in a new perfluorohexyloctane (F6H8) emulsion in rats – a comparative study. Int J Pharm. 486:69–76.
  • Winter PM. 2014. Perfluorocarbon nanoparticles: evolution of a multimodality and multifunctional imaging agent. Scientifica (Cairo). 2014:746574.
  • Wolters M, Mohades SG, Hackeng TM, Post MJ, Kooi ME, Backes WH. 2013. Clinical perspectives of hybrid proton-fluorine magnetic resonance imaging and spectroscopy. Invest Radiol. 48:341–350.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.